[1]
Eshmuratov Sardor Eldorovich and Uralov Rustam Sherbekovich, “THE CLINICAL SIGNIFICANCE OF INTERLEUKIN-4 IN SYSTEMIC SCLERODERMA”, Spec. Jour. of Inno. Ref. and Dev., vol. 27, pp. 51–58, May 2024.